Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/10/004060
CTRI/2013/10/004060
Completed
未知

Evaluation of efficacy of Dexmedetomidine for prevention of catheter related bladder discomfort in patients undergoing laproscopic donor nephrectomy: a prospective, randomized, double-blind study

Dr Anil Agarwal0 sites110 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Anil Agarwal
Enrollment
110
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 30, 2015
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •voluntary kidney donors

Exclusion Criteria

  • •Patients with history of
  • •\-outflow obstruction
  • •\- Transurethral resection of prostate for benign prostatic hyperplasia
  • •\-history of bladder catheterization within last 6 months
  • •\-re look Percutaneous Nephrolithotomy
  • •\- Pre\-existing Percutaneous Nephrostomy
  • •\-deranged renal function
  • •\-urine on culture and sentivity found unsterile
  • •\-elderly patients (age Ë? 60 yrs),
  • •\-overactive bladder (frequency \>3 times in the night or \>8 times in 24 h)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Evaluation of the effectiveness of dexmedetomidineine sedation of COVID-19 critically ill patients
IRCT20110425006280N13Vice President of Research Guilan university of medical sciences60
Completed
Phase 3
Evaluation of dexmedetomidine in reducing postoperative ocular pai
IRCT20200503047291N1Mashhad University of Medical Sciences30
Completed
Phase 1
Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoringSpinal cord tumors, spinal disorders
JPRN-UMIN000009044iigata University Medical and Dental Hospital, Anesthesiology10
Completed
Phase 2
Study about efficacy of Dexmedetomidine as a novel sedative agent during ESD for esophageal cancer
JPRN-UMIN000017302Department of Gastroenterology,Cancer Institute Hospital65
Completed
Phase 2
The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.Inguinal hernia.Inguinal hernia
IRCT2016060314372N8Vice Chancellor for Research, Shiraz University of Medical Sciences60